TP53 and medulloblastoma: DNA sequencing results indicated that p53 gene mutations in this series of cPNETs were infrequent, which was consistent with the findings from other studies (Saylors et al, 1991; Adesina, 1994) and could explain the high sensitivity of medulloblastoma cells to radio therapy (Chang et al, 1969).